Guangzhou Baiy | 600332 - Gross Profit On Sales


Guangzhou Baiy reported CNY4.73B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 39.1B 2.54B Mar/2026
Dr.Reddys Laboratories INR 37.77B 13.6B Mar/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Kalbe Farma IDR 3.45T 151.13B Sep/2025
Richter Gedeon HUF 143.37B 25.78B Sep/2025
Sh Fosun Pharma CNY 6.69B 1.9B Dec/2025
Sh Pharmaceutical CNY 7.45B 223.01M Sep/2025
Sun Pharmaceuticals INR 125.24B 17.58B Dec/2025
Teva Pharmaceutical Industries USD 2.11B 547M Mar/2026